Gavin O’Mahony

1.2k total citations
36 papers, 808 citations indexed

About

Gavin O’Mahony is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Gavin O’Mahony has authored 36 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Surgery. Recurrent topics in Gavin O’Mahony's work include Peroxisome Proliferator-Activated Receptors (6 papers), Microbial Natural Products and Biosynthesis (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Gavin O’Mahony is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Microbial Natural Products and Biosynthesis (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Gavin O’Mahony collaborates with scholars based in Sweden, United States and United Kingdom. Gavin O’Mahony's co-authors include Christian Ottmann, Eline Sijbesma, Anna Karawajczyk, Jeremy Davis, Michael M. Hann, Luc Brunsveld, Jan Eickhoff, Richard G. Doveston, Morten Grøtli and Peter Gennemark and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Gavin O’Mahony

36 papers receiving 800 citations

Peers

Countries citing papers authored by Gavin O’Mahony

Since Specialization

Citations

This map shows the geographic impact of Gavin O’Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin O’Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin O’Mahony more than expected).

Fields of papers citing papers by Gavin O’Mahony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin O’Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin O’Mahony. The network helps show where Gavin O’Mahony may publish in the future.

Co-authorship network of co-authors of Gavin O’Mahony

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin O’Mahony. A scholar is included among the top collaborators of Gavin O’Mahony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin O’Mahony. Gavin O’Mahony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism 2024 ·JCI Insight ·Sehyung Park, (unknown), Lindsey R. Conroy, Harrison A. Clarke, Ramon C. Sun, Kristina Wallenius, Jérémie Boucher, Gavin O’Mahony, Alessandro Boianelli, (unknown), Sunhee Jung, Cholsoon Jang, Analia S. Loria, (unknown), Zachary A. Kipp, (unknown), Terry D. Hinds, Senad Divanovic, Samir Softic	5
2	Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein–Protein Interaction 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Sebastian A. Andrei, K. A. P. Edman, Anders Gunnarsson, Giuseppina La Sala, Okky Dwichandra Putra, (unknown), Andrew J. Wilson, Lisa Wissler, Christian Ottmann, Matthew W. D. Perry, Gavin O’Mahony	9
3	Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation 2022 ·ACS Medicinal Chemistry Letters ·Gavin O’Mahony, Jens Petersen, Margareta Ek, (unknown), Carina Johansson, Jianming Liu, Nina Prokoph, Fredrik Bergström, Krister Bamberg, Fabrizio Giordanetto, Bader Zarrouki, Daniel Karlsson, Anders Hogner	13
4	A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes 2021 ·STAR Protocols ·Sehyung Park, Robert N. Helsley, Leila Noetzli, Ho-Chou Tu, Kristina Wallenius, Gavin O’Mahony, Jérémie Boucher, Jianming Liu, Samir Softic	5
5	Chronic treatment with terbutaline increases glucose and oleic acid oxidation and protein synthesis in cultured human myotubes 2021 ·SHILAP Revista de lepidopterología ·(unknown), Tuula A. Nyman, Xiaorong Peng, Gavin O’Mahony, Eili Tranheim Kase, Arild C. Rustan, G. Hege Thoresen	3
6	PPARγ and PPARα synergize to induce robust browning of white fat in vivo 2020 ·Molecular Metabolism ·(unknown), Matthew Harms, Stefanie Maurer, L Bonnet, Ida Alexandersson, Anna Lindblom, Andrea Ahnmark, Daniel Nilsson, Peter Gennemark, Gavin O’Mahony, (unknown), Coleen A. McNamara, Jérémie Boucher	64
7	In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects 2019 ·Theranostics ·(unknown), (unknown), (unknown), Matthew Harms, (unknown), Melissa A. Marshall, James C. Garmey, Anh T. Nguyen, (unknown), Aditi Upadhye, Prasad Srikakulapu, (unknown), Gavin O’Mahony, Alexander L. Klibanov, Kimberly Kelly, Jérémie Boucher, Coleen A. McNamara	17
8	Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects 2019 ·PLoS ONE ·(unknown), (unknown), (unknown), Anh T. Nguyen, Melissa A. Marshall, (unknown), Matthew Harms, Gavin O’Mahony, Jérémie Boucher, Alexander L. Klibanov, Coleen A. McNamara, (unknown)	3
9	Modulators of 14-3-3 Protein–Protein Interactions 2017 ·Journal of Medicinal Chemistry ·Loes M. Stevers, Eline Sijbesma, Maurizio Botta, Carol MacKintosh, Tomáš Obšil, Isabelle Landrieu, Ylenia Cau, Andrew J. Wilson, Anna Karawajczyk, Jan Eickhoff, Jeremy Davis, Michael M. Hann, Gavin O’Mahony, Richard G. Doveston, Luc Brunsveld, Christian Ottmann	210
10	Adipose Tissue–Preserved Skin Graft: Applicability and Long-Term Results 2017 ·Plastic & Reconstructive Surgery ·Bryan Chung, Gavin O’Mahony, Gretl Lam, David Chiu	5
11	Toward molecular imaging of the free fatty acid receptor 1 2017 ·Acta Diabetologica ·Ewa Hellström‐Lindahl, Ola Åberg, Cecilia Ericsson, Gavin O’Mahony, Peter Johnström, Stanko Skrtic, Olof Eriksson	1
12	Development of an ELISA for High-Throughput Screening of Inhibitors of Cdk5-Mediated PPARγ Phosphorylation 2016 ·Assay and Drug Development Technologies ·Nina Prokoph, Mats Ormö, Gavin O’Mahony, Anders Hogner, Jane McPheat, Ulla Karlsson, Lovisa Holmberg Schiavone, Jianming Liu	5
13	Characterisation of de novo mutations in the C-terminal domain of proprotein convertase subtilisin/kexin type 9 2015 ·Protein Engineering Design and Selection ·Stefan Geschwindner, Gunilla Andersson, Hans‐Georg Beisel, Sebastian Breuer, Carina Hallberg, Britt‐Marie Kihlberg, (unknown), Gavin O’Mahony, Alleyn T. Plowright, Florian Raubacher, Wolfgang Knecht	6
14	Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity 2015 ·Frontiers in Endocrinology ·Xiaorong Peng, Peter Gennemark, Gavin O’Mahony, Stefano Bartesaghi	44
15	Identification and design of a novel series of MGAT2 inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Linda K. Buckett, (unknown), Öjvind Davidsson, Hans Emtenäs, Anne Ertan, Ulrik Jurva, Malin Lemurell, Pablo Morentin Gutierrez, Karolina Nilsson, Gavin O’Mahony, Annika Petersson, (unknown), Fredrik Wågberg, (unknown)	25
16	Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Udo Bauer, Fabrizio Giordanetto, Martin Bauer, Gavin O’Mahony, (unknown), Wolfgang Knecht, (unknown), (unknown), Cristofer Enroth	22
17	NMR-Based Substrate Analog Docking to Escherichia coli Peptidyl-tRNA Hydrolase 2011 ·Journal of Molecular Biology ·(unknown), Pierre Plateau, Gavin O’Mahony, (unknown), Michel Fromant, Aurélien Thureau, Morten Grøtli, Sylvain Blanquet, François Bontems	19
18	Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, Antonio Llinàs, Anders Lindqvist, Qing‐Dong Wang, (unknown), (unknown), (unknown), Kristina Nilsson, Gavin O’Mahony, (unknown), (unknown), Annika Åstrand, Göran Duker	5
19	A practical synthesis of 2′-aminoacylamino-2′-deoxyadenosines 2007 ·Tetrahedron ·Gavin O’Mahony, Andreas Sundgren, Sara Svensson, Morten Grøtli	3
20	Discovering New Classes of Brugia malayi Asparaginyl-tRNA Synthetase Inhibitors and Relating Specificity to Conformational Change 2006 ·Journal of Computer-Aided Molecular Design ·Sai Chetan K. Sukuru, Thibaut Crépin, (unknown), (unknown), Jonathan B. Hill, R. J. Anderson, Jonathan C. Morris, (unknown), Gavin O’Mahony, Morten Grøtli, Franck Danel, Malcolm G. P. Page, Michael Härtlein, S. Cusack, Michael Kron, Leslie A. Kuhn	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact